Filter News
Area of Research
News Topics
- (-) Bioenergy (2)
- (-) Biomedical (3)
- (-) Grid (3)
- 3-D Printing/Advanced Manufacturing (4)
- Buildings (2)
- Chemical Sciences (12)
- Climate Change (3)
- Composites (3)
- Computer Science (1)
- Coronavirus (1)
- Critical Materials (1)
- Decarbonization (4)
- Energy Storage (4)
- Environment (3)
- Fusion (2)
- Isotopes (7)
- Materials (34)
- Materials Science (8)
- Microscopy (5)
- Molten Salt (1)
- Nanotechnology (5)
- Net Zero (1)
- Neutron Science (9)
- Nuclear Energy (4)
- Partnerships (6)
- Physics (11)
- Polymers (5)
- Quantum Computing (1)
- Quantum Science (1)
- Renewable Energy (1)
- Sustainable Energy (1)
- Transportation (2)
Media Contacts
In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — Oak Ridge National Laboratory was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
Oak Ridge National Laboratory scientists have developed a crucial component for a new kind of low-cost stationary battery system utilizing common materials and designed for grid-scale electricity storage. Large, economical electricity storage systems can benefit the nation’s grid ...
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...